PPP1R1B and Huntington disease: It has been shown to reduce motor and cognitive impairments in a 3-nitropropionic acid (3-NP) HD rat model [16] and decreases mHTT aggregates, while preserving DARPP-32 and D1 receptors, in the CAG 140 knock-in mouse model of HD [17].